Providence Regional Cancer System — Lacey, Washington

Providence Regional Cancer System is a clinical research site located in Lacey, Washington, United States 98503.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Providence Regional Cancer System has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Metastatic Non Small Cell Lung Cancer, Prostate Cancer Metastatic, Castration-resistant Prostate Cancer.

Sponsors: Daiichi Sankyo, Hinova Pharmaceuticals USA, Inc., Spectrum Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer System?

Providence Regional Cancer System has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer System conducted?

Providence Regional Cancer System has 9 clinical trials on record, with 5 currently active. Their work covers Metastatic Non Small Cell Lung Cancer, Prostate Cancer Metastatic, Castration-resistant Prostate Cancer.

Is Providence Regional Cancer System accredited by Crixeo Health?

Yes — Providence Regional Cancer System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Providence Regional Cancer System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.